Moderna's gene therapy expansion picks up pace with $76M upfront Generation Bio collab
Disgraced former Seagen CEO tapped to lead MorphImmune less than a year after domestic assault arrest
Sanofi and Regeneron's Dupixent scores trial win in tough-to-treat COPD
AbbVie's Skyrizi aces ulcerative colitis study
*please scroll down for all the latest news*
